|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,938.00 DKK | +0.34% |
|
-7.27% | -4.39% |
| 04/02 | Goldman Sachs Lowers Price Target for Genmab to 1,793 Danish Kroner (from 1,880), Reiterates Neutral - BN | FW |
| 04/02 | Fitch Highlights Genmab's Antibody Oncology Leadership in Final Rating | MT |
Quotes 5-day view: Genmab A/S
Delayed Quote Nasdaq Copenhagen
| 04/02/2026 | 05/02/2026 | 06/02/2026 | 09/02/2026 | 10/02/2026 | |
|---|---|---|---|---|---|
| Last | 2,007.00 kr | 1,987.50 kr | 1,958.00 kr | 1,931.50 kr | 1,938.00 kr |
| Volume | 1,14,802 | 1,12,367 | 1,04,993 | 1,04,911 | 1,07,858 |
| Change | -4.29% | -0.97% | -1.48% | -1.35% | +0.34% |
| Opening | 2,064.00 kr | 1,982.00 kr | 1,970.50 kr | 1,955.00 kr | 1,940.00 kr |
| High | 2,070.00 kr | 2,023.00 kr | 1,976.00 kr | 1,982.50 kr | 1,940.00 kr |
| Low | 2,007.00 kr | 1,963.50 kr | 1,941.50 kr | 1,924.00 kr | 1,920.00 kr |
Performance
| 1 day | +0.34% | ||
| 1 week | -7.27% | ||
| Current month | -4.15% | ||
| 1 month | -11.18% | ||
| 3 months | +4.90% | ||
| 6 months | +40.23% | ||
| Current year | -4.39% | ||
| 1 year | +39.93% | ||
| 3 years | -30.21% | ||
| 5 years | -23.00% | ||
| 10 years | +203.76% |
Volumes
marketsDaily volume
1,07,858
Estimated daily volume
1,07,858
Avg. Volume 20 sessions
1,09,742
Daily volume ratio
0.98
Avg. Volume 20 sessions DKK
21,26,79,996
Avg. Volume 20 sessions USD
3,38,74,393.68
Record volume 1
60,40,205
Record volume 2
34,95,448
Record volume 3
33,21,429
Capital turnover ratio
0
Float rotation
0
Basic data
Capitalization (DKK)
1,18,93,18,81,843
Capitalization (USD)
18,94,76,41,395
Net sales (DKK)
21,52,60,00,000
Net sales (USD)
3,42,94,16,254
Number of employees
2,681
Sales / Employee (DKK)
80,29,094
Sales / Employee (USD)
12,79,156
Free-Float
95.94 %
Free-Float capitalization (DKK)
1,22,59,95,83,477
Free-Float capitalization (USD)
19,53,19,61,547
Average Daily Capital Traded
0.18%
Indicators
Moving average 5 days
1,996.2
Moving average 20 days
2,091.48
Moving average 50 days
2,065.81
Moving average 100 days
2,000.37
Price spread / (MMA5)
+3.00%
Price spread / (MMA20)
+7.92%
Price spread / (MMA50)
+6.59%
Price spread / (MMA100)
+3.22%
STIM
RSI 9 days
36
RSI 14 days
40.73
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | -7.27% | +39.93% | -30.21% | 1.89TCr | |
| +1.05% | -0.64% | +12.18% | +102.46% | 5.11TCr | |
| +2.68% | +8.74% | +74.23% | +10.98% | 4.26TCr | |
| -0.66% | -3.53% | +85.80% | +648.74% | 3.19TCr | |
| -1.28% | +0.05% | -7.38% | -22.49% | 2.77TCr | |
| +2.45% | +11.03% | +88.35% | -36.39% | 2.02TCr | |
| -0.27% | +8.91% | +141.26% | - | 1.25TCr | |
| +0.09% | +4.76% | +63.75% | +137.53% | 1.2TCr | |
| -2.21% | +0.40% | +28.38% | +144.48% | 1.18TCr | |
| +1.87% | +8.46% | -24.17% | +514.92% | 1.15TCr | |
| Average | +0.44% | +1.03% | +50.23% | +163.33% | 2.4TCr | |
| Weighted average by Cap. | +0.69% | +0.70% | +47.64% | +148.22% |
Historical Quotes: Genmab A/S
| Date | Opening | High | Low | End-of-day | Volume | Change |
|---|
Latest transactions
38faf75.hrGs6XeVAVZzS1r7uMSOQpcLRCAHP7oUTEiZedb9h1o.6tvCuiPvVhs4Zgq41aq3cfxKL1dGceBbBnD_Sr65tCCy6M-CQ6VVECAKCw
| Date | Price | Volume | Total |
|---|---|---|---|
| 09:29:42 pm | 1,938.00 | 210 | 1,02,125 |
| 09:29:42 pm | 1,938.00 | 50 | 1,01,915 |
| 09:29:42 pm | 1,938.00 | 10 | 1,01,865 |
| 09:29:42 pm | 1,938.00 | 391 | 1,01,855 |
| 09:29:42 pm | 1,938.00 | 639 | 1,01,464 |
| 09:29:42 pm | 1,938.00 | 36 | 1,00,825 |
| 09:29:42 pm | 1,938.00 | 155 | 1,00,789 |
| 09:29:42 pm | 1,938.00 | 129 | 1,00,634 |
| 09:29:42 pm | 1,938.00 | 150 | 1,00,505 |
| 09:29:42 pm | 1,938.00 | 42 | 1,00,355 |
Course Extremes
| 1 week | 1,920 |  | 2,070 |
| 1 month | 1,920 | | 2,257 |
| Current year | 1,920 | | 2,257 |
| 1 year | 1,157 | | 2,257 |
| 3 years | 1,157 | | 2,947 |
| 5 years | 1,157 | | 3,327 |
| 10 years | 634.5 | | 3,327 |
Monthly variations
Annual variations
| 2026 | -4.39% | ||
| 2025 | +35.81% | ||
| 2024 | -30.74% | ||
| 2023 | -26.73% | ||
| 2022 | +11.83% | ||
| 2021 | +6.78% | ||
| 2020 | +66.25% | ||
| 2019 | +38.78% | ||
| 2018 | +3.74% | ||
| 2017 | -12.28% | ||
| 2016 | +27.85% | ||
| 2015 | +154.65% | ||
| 2014 | +69.95% | ||
| 2013 | +172.49% | ||
| 2012 | +106.91% | ||
| 2011 | -42.60% | ||
| 2010 | -20.12% | ||
| 2009 | -59.61% | ||
| 2008 | -34.30% | ||
| 2007 | -18.68% | ||
| 2006 | +181.48% | ||
| 2005 | +35.00% | ||
| 2004 | +96.08% | ||
| 2003 | +108.16% | ||
| 2002 | -85.76% | ||
| 2001 | -6.01% | ||
| 2000 | -21.46% |
- Stock Market
- Equities
- GMAB Stock
- Quotes Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition